Ignite Creation Date:
2025-12-24 @ 4:37 PM
Ignite Modification Date:
2026-02-22 @ 5:23 PM
Study NCT ID:
NCT01902966
Status:
TERMINATED
Last Update Posted:
2021-10-12
First Post:
2013-07-12
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Feasibility - Beta Adrenergic Blockade (BB) in Cervical Cancer (CX)
Sponsor:
M.D. Anderson Cancer Center
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
2013-0113
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None